STOCK TITAN

Introducing Sivanto Energy: Enhanced Flea Beetle Control

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Key Terms

foliar insecticide medical
A foliar insecticide is a pesticide sprayed directly onto the leaves of plants to kill or repel insects that feed on or damage crops; think of it as targeted pest control on the plant’s “skin.” Investors care because its use affects crop yields, input costs, and regulatory or environmental risk, which in turn influence farm profitability, demand for agricultural chemicals, and the stability of food supply chains.
modes of action medical
Modes of action describe the specific way a drug, chemical, or treatment produces its effect in the body — essentially the biological mechanism or pathway it uses, like which molecule it targets or which cell process it alters. For investors, understanding a product's mode of action matters because it indicates how likely the treatment is to work, whether it fills an unmet need, and how it might compete with or complement other therapies, similar to knowing how different tools solve the same problem.
deltamethrin medical
Deltamethrin is a synthetic insecticide widely used to kill insects on crops, in homes, and in public health applications like mosquito control; it works quickly by disrupting insect nerve function. Investors watch deltamethrin because regulatory approvals, safety reviews, or restrictions can directly affect sales, product liability risks, and demand for crop-protection and pest-control companies—think of it as a fast-acting bug zapper whose legal status and supply influence industry revenue and crop yields.
flupyradifurone medical
Flupyradifurone is a synthetic crop insecticide absorbed and distributed through plants to kill sap-feeding insects by disrupting their nervous signals; it is chemically distinct from older pesticides but performs a similar job. For investors, it matters because sales hinge on farm demand, regulatory approvals or restrictions, and environmental or pollinator concerns—think of it as a new tool farmers may buy to protect yields, whose market value depends on safety rules and crop economics.
residual activity medical
Residual activity is the amount of biological effect or function that remains after a treatment, exposure, or passage of time — for example, the leftover ability of a drug, antibody, enzyme, or pathogen to act. It matters to investors because it affects how long a therapy works, dosing schedules, safety and regulatory review, and ultimately market demand and revenue potential; think of it like how long a battery still holds charge after use.

CALGARY, Alberta--(BUSINESS WIRE)-- Bayer Crop Science Canada is excited to announce the launch of Sivanto® Energy, a groundbreaking foliar insecticide designed to deliver swift, reliable pest control with extended protection. Formulated to deliver two highly effective modes of action, Sivanto Energy combines the strengths of deltamethrin and flupyradifurone to provide unparalleled control over flea beetle pressure in canola.

Dual Action Formula for Exceptional Control

Sivanto Energy harnesses the power of two active ingredients: Group 3 insecticide deltamethrin and Group 4D insecticide flupyradifurone. "This integrated multiple active ingredient approach not only ensures comprehensive pest management but also provides growers with the flexibility they need," said Ashley Smith, SeedGrowth & Broadacre Insecticide Product Manager at Bayer. "It's about empowering farmers to protect their canola with effective tools that help manage pests and time on their farms.”

Fast and Systemic Protection

One of the standout features of Sivanto Energy is its rapid action coupled with long-lasting residual activity. This insecticide provides systemic protection for up to 4 days, ensuring that crops remain safeguarded against flea beetles. "With Sivanto Energy, farmers can have peace of mind knowing their canola - fields are protected, allowing them to focus on other aspects that lead to a successful harvest on their operations," noted Bryan Bryson, Marketing Portfolio Lead. "This product truly represents the next generation of flea beetle protection."

About Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people, and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses before special items amounted to 6.2 billion euros.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

For further information or to arrange an interview, contact:



Communications Department

Bayer Inc.

mediacanada@bayer.com

Source: Bayer

Bayer Aktien

OTC:BAYRY

BAYRY Rankings

BAYRY Latest News

BAYRY Stock Data

33.21B
3.93B
0.59%
Drug Manufacturers - General
Healthcare
Link
Germany
Leverkusen